HtmlToText
iarc screening group english français -- home research projects breast cancer cancer control cervical cancer colorectal cancer oral cancer training manuals elearning courses digital learning series video tutorials other useful screening videos audio presentations quick clinical reference charts online library scr publications scientific papers collaborators about the group visitors and news menu home research projects cervical cancer breast cancer oral cancer hpv vaccine training materials manuals elearning courses digital learning series video tutorials other useful screening videos audio presentations quick clinical reference charts online library scr publications scientific papers collaborators about the group visitors and news home the core function of the screening group (scr) at iarc is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients quality of life in various settings. these data can then be used to inform and improve the rational use of health-care resources. the groups ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (lmics). scr conducts field studies in lmics to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. these initiatives also address the means by which screening services could be scaled up through local public health services. scr develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. through its research programme, scr generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. for example, the group significantly contributed to the evaluation of the safety and efficacy of less than three doses of the hpv vaccine in protecting against cervical cancer. -- visitors and news meeting: the 2019 annual scientific meeting of the british society for colposcopy and cervical pathology (bsccp), bournemouth, united kingdom 08/05/2019 10/05/2019 dr basu has been invited as speaker during the the british society for colposcopy and cervical pathology (bsccp) annual scientific meeting and discussed about worldwide initiatives for prevention of cervical cancers and vaccination status in low-middle income countries. visit of dr yogesh verma, sikkim manipal institute of medical sciences, gangtok, sikkim 06/05/2019 10/05/2019 dr yogesh verma visited the screening group to work on an analysis and preparation of a new manuscript for the extended follow-up of the participants of the hpv vaccine trial to evaluate the effectiveness of one, two, and three doses of quadrivalent hpv vaccine in preventing cervical neoplasia. benefits and harms of lung cancer screening 08/05/2019 iarc released this new fact sheet to summarize the benefits and harms of lung cancer screening with a modern protocol. view the fact sheet , the associated video and the recent article published in the lancet respiratory medicine by dr paul brennan team. all visitors and news scientific papers mahajan m., naik n., jain k., patira n., prasad s., mogri s., muwonge r ., lucas e ., faruq f., sankaranarayanan r ., iyer s., basu p . study of knowledge, attitudes, and practices toward risk factors and early detection of noncommunicable diseases among rural women in india. j glob oncol. 2019 apr;(5):1-10. pmid: 30998427 vale d.b., sauvaget c ., murillo r., muwonge r ., zeferino l.c., sankaranarayanan r . correlation of cervical cancer mortality with fertility, access to health care and socioeconomic indicators. rev bras ginecol obstet. 2019 mar 25. pmid: 30912091 gadgil a., sauvaget c ., roy n., muwonge r ., lucas e ., sankaranarayanan r . setting up a breast cancer awareness project in mumbai: methodology, experiences and challenges. j cancer educ. 2019 mar 12. doi: 10.1007/s13187-019-01500-x. pmid: 30863980 all scientific papers iarc, 150 cours albert thomas, 69372 lyon cedex 08, france - tel: +33 (0)4 72 73 84 85 - fax: +33 (0)4 72 73 85 75 © iarc 2019 - all rights reserved .
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
%%
%% This is the AFNIC Whois server.
%%
%% complete date format : DD/MM/YYYY
%% short date format : DD/MM
%% version : FRNIC-2.5
%%
%% Rights restricted by copyright.
%% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%%
%% Use '-h' option to obtain more information about this service.
%%
%% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> iarc.fr
%%
%% RL Net [##########] - RL IP [#########.]
%%
domain: iarc.fr
status: ACTIVE
hold: NO
holder-c: IAFR1-FRNIC
admin-c: MS5771-FRNIC
tech-c: GR1378-FRNIC
zone-c: NFC1-FRNIC
nsl-id: NSL50420-FRNIC
registrar: GIP RENATER
Expiry Date: 31/12/2017
created: 01/01/1995
last-update: 31/12/2016
source: FRNIC
ns-list: NSL50420-FRNIC
nserver: ns1.iarc.fr [193.51.164.138]
nserver: dnsext.iarc.fr [193.51.164.142]
nserver: ccpntc3.in2p3.fr [134.158.69.191]
nserver: ccpnvx.in2p3.fr [134.158.69.104]
source: FRNIC
registrar: GIP RENATER
type: Isp Option 1
address: 23-25 Rue Daviel
address: PARIS
country: FR
phone: +33 1 53 94 20 30
fax-no: +33 1 53 94 20 31
e-mail: domaine@renater.fr
website: http://www.renater.fr
anonymous: NO
registered: 01/01/1998
source: FRNIC
nic-hdl: IAFR1-FRNIC
type: ORGANIZATION
contact: International Agency for Research on Cancer
address: 150, cours Albert Thomas
address: 69372 Lyon Cedex 8
country: FR
registrar: GIP RENATER
changed: 09/10/2008 whoismaster@nic.fr
anonymous: NO
obsoleted: NO
source: FRNIC
nic-hdl: MS5771-FRNIC
type: PERSON
contact: Michel Smans
address: International Agency for Research on Cancer
address: 150, cours Albert Thomas
address: 69372 Lyon Cedex 8
country: FR
phone: +33 72 73 84 31
fax-no: +33 72 73 85 75
e-mail: smans@friarc51.bitnet
notify: smans@friarc51.bitnet
registrar: GIP RENATER
changed: 15/10/2000 migration-dbm@nic.fr
anonymous: NO
obsoleted: NO
source: FRNIC
nic-hdl: GR1378-FRNIC
type: ROLE
contact: GIP RENATER
address: GIP RENATER
address: Ensam
address: 151, boulevard de l'Hopital
address: 75013 Paris
country: FR
phone: +33 1 53 94 20 30
fax-no: +33 1 53 94 20 31
e-mail: rensvp@renater.fr
trouble: Information: http://www.Renater.fr/
trouble: abuse reports, ... mailto:CertSVP@Renater.fr
trouble: questions: mailto:RenSVP@Renater.Fr
admin-c: DV321-FRNIC
tech-c: FS65-FRNIC
tech-c: BT261-FRNIC
tech-c: MD5336-FRNIC
tech-c: SJ94-FRNIC
tech-c: ED168-FRNIC
tech-c: CT1053-FRNIC
tech-c: SEH1-FRNIC
tech-c: FXA1-FRNIC
registrar: GIP RENATER
changed: 08/11/2005 rensvp@renater.fr
anonymous: NO
obsoleted: NO
source: FRNIC
REFERRER http://www.nic.fr
REGISTRAR AFNIC
SERVERS
SERVER fr.whois-servers.net
ARGS iarc.fr
PORT 43
TYPE domain
RegrInfo
DISCLAIMER
%
% This is the AFNIC Whois server.
%
% complete date format : DD/MM/YYYY
% short date format : DD/MM
% version : FRNIC-2.5
%
% Rights restricted by copyright.
% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%
% Use '-h' option to obtain more information about this service.
%
% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> iarc.fr
%
% RL Net [##########] - RL IP [#########.]
%
REGISTERED yes
ADMIN
HANDLE MS5771-FRNIC
TYPE PERSON
CONTACT Michel Smans
ADDRESS
International Agency for Research on Cancer
150, cours Albert Thomas
69372 Lyon Cedex 8
COUNTRY FR
PHONE +33 72 73 84 31
FAX +33 72 73 85 75
EMAIL smans@friarc51.bitnet
NOTIFY smans@friarc51.bitnet
SPONSOR GIP RENATER
CHANGED 2000-10-15
ANONYMOUS NO
OBSOLETED NO
SOURCE FRNIC
TECH
HANDLE GR1378-FRNIC
TYPE ROLE
CONTACT GIP RENATER
ADDRESS
GIP RENATER
Ensam
151, boulevard de l'Hopital
75013 Paris
COUNTRY FR
PHONE +33 1 53 94 20 30
FAX +33 1 53 94 20 31
EMAIL rensvp@renater.fr
TROUBLE
Information: http://www.Renater.fr/
abuse reports, ... mailto:CertSVP@Renater.fr
questions: mailto:RenSVP@Renater.Fr
ADMIN-C DV321-FRNIC
TECH-C
FS65-FRNIC
BT261-FRNIC
MD5336-FRNIC
SJ94-FRNIC
ED168-FRNIC
CT1053-FRNIC
SEH1-FRNIC
FXA1-FRNIC
SPONSOR GIP RENATER
CHANGED 2005-11-08
ANONYMOUS NO
OBSOLETED NO
SOURCE FRNIC
OWNER
HANDLE IAFR1-FRNIC
TYPE ORGANIZATION
CONTACT International Agency for Research on Cancer
ADDRESS
150, cours Albert Thomas
69372 Lyon Cedex 8
COUNTRY FR
SPONSOR GIP RENATER
CHANGED 2008-10-09
ANONYMOUS NO
OBSOLETED NO
SOURCE FRNIC
DOMAIN
STATUS ACTIVE
HOLD NO
SPONSOR GIP RENATER
EXPIRY DATE 31/12/2017
CREATED 1995-01-01
CHANGED 2016-12-31
SOURCE FRNIC
HANDLE NSL50420-FRNIC
NSERVER
NS1.IARC.FR 193.51.164.138
DNSEXT.IARC.FR 193.51.164.142
CCPNTC3.IN2P3.FR 134.158.69.191
CCPNVX.IN2P3.FR 134.158.69.104
NAME iarc.fr
Go to top
screening.iarc.fr rapport :
Visitez le site